ImmunityBio
(NASDAQ:IBRX)
$4.55
-0.18[-3.81%]
At close: Aug 16
$4.55
After Hours: 4:01PM EDT
Day High/Low4.36 - 4.76
52 Week High/Low2.6 - 7.85
Open / Close4.76 / 4.55
Float / Outstanding- / 400.3M
Vol / Avg.- / 1.8M
Mkt Cap1.8B
P/E-
50d Avg. Price4.08
Div / Yield-
Payout Ratio-
EPS-0.24
Total Float83.5M

ImmunityBio (NASDAQ:IBRX), Quotes and News Summary

ImmunityBio (NASDAQ: IBRX)

Day High/Low4.36 - 4.76
52 Week High/Low2.6 - 7.85
Open / Close4.76 / 4.55
Float / Outstanding- / 400.3M
Vol / Avg.- / 1.8M
Mkt Cap1.8B
P/E-
50d Avg. Price4.08
Div / Yield-
Payout Ratio-
EPS-0.24
Total Float83.5M
Sector: Health Care.Industry: Biotechnology
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-11
REV
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-30
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

ImmunityBio Questions & Answers

Q
How do I buy ImmunityBio (IBRX) stock?
A

You can purchase shares of ImmunityBio (NASDAQ: IBRX) through any online brokerage.

View our list of the best stock brokerages.

Q
What is the target price for ImmunityBio (IBRX) stock?
A

The latest price target for ImmunityBio (NASDAQ: IBRX) was reported by Jefferies on Wednesday, August 3, 2022. The analyst firm set a price target for 8.00 expecting IBRX to rise to within 12 months (a possible 75.82% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for ImmunityBio (IBRX)?
A

The stock price for ImmunityBio (NASDAQ: IBRX) is $4.55 last updated August 16, 2022, 8:00 PM UTC.

Q
Does ImmunityBio (IBRX) pay a dividend?
A

There are no upcoming dividends for ImmunityBio.

Q
When is ImmunityBio (NASDAQ:IBRX) reporting earnings?
A

ImmunityBio’s Q3 earnings are confirmed for Friday, November 11, 2022.

Q
Is ImmunityBio (IBRX) going to split?
A

There is no upcoming split for ImmunityBio.

Q
What sector and industry does ImmunityBio (IBRX) operate in?
A

ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.